Hemangioendothelioma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Condition: Epithelioid Hemangioendothelioma Interventions: Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration; Drug: Trametinib Sponsor: National Cancer Institute (NCI) Recruiting - verified May 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2017 Category: Research Source Type: clinical trials
